Quiescin Sulfhydryl Oxidase 1 Regulates the Proliferation, Migration and Invasion of Human Glioblastoma Cells via PI3K/Akt Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quiescin Sulfhydryl Oxidase 1 Regulates the Proliferation, Migration and Invasion of Human Glioblastoma Cells via PI3K/Akt Pathway
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 5721-5729
Publisher
Informa UK Limited
Online
2020-06-17
DOI
10.2147/ott.s255941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CLEC5A promotes the proliferation of gastric cancer cells by activating the PI3K/AKT/mTOR pathway
- (2020) Quhui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells
- (2020) Kun Yang et al. ONCOLOGY REPORTS
- Does the expression of glial fibrillary acid protein (GFAP) stain in glioblastoma tissue have a prognostic impact on survival?
- (2020) Y. Ahmadipour et al. NEUROCHIRURGIE
- Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
- (2020) Thomas J. Kaley et al. Annals of Clinical and Translational Neurology
- Targeted Therapies for the Treatment of Glioblastoma in Adults
- (2019) Ding Fang Chuang et al. Current Oncology Reports
- Molecular Inhibitor of QSOX1 Suppresses Tumor Growth in vivo
- (2019) Amber L Fifield et al. MOLECULAR CANCER THERAPEUTICS
- A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study
- (2019) Sarah Lapointe et al. INVESTIGATIONAL NEW DRUGS
- Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells
- (2019) Bryan G. Harder et al. MOLECULAR MEDICINE
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- High expression of QSOX1 is associated with tumor invasiveness and high grades groups in prostate cancer
- (2018) Jin A. Baek et al. PATHOLOGY RESEARCH AND PRACTICE
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis
- (2018) Hye-Jin Sung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Persistent Expression of VCAM1 in Radial Glial Cells Is Required for the Embryonic Origin of Postnatal Neural Stem Cells
- (2017) Xiao-Ling Hu et al. NEURON
- Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors
- (2017) Cheng Xu et al. Oncotarget
- Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
- (2017) Wojciech Szopa et al. Biomed Research International
- QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas
- (2016) Gøril Knutsvik et al. MODERN PATHOLOGY
- Role of EMT in Metastasis and Therapy Resistance
- (2016) Bethany Smith et al. Journal of Clinical Medicine
- EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling
- (2015) Feng Liu et al. MOLECULAR CELL
- Mechanisms involved in kinin-induced glioma cells proliferation: the role of ERK1/2 and PI3K/Akt pathways
- (2014) Natália Fontana Nicoletti et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
- (2014) Daniel J. Ma et al. NEURO-ONCOLOGY
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- An Inhibitory Antibody Blocks the First Step in the Dithiol/Disulfide Relay Mechanism of the Enzyme QSOX1
- (2013) Iris Grossman et al. JOURNAL OF MOLECULAR BIOLOGY
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
- (2013) A. Sottoriva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Secreted Disulfide Catalyst Controls Extracellular Matrix Composition and Function
- (2013) T. Ilani et al. SCIENCE
- Epithelial-to-Mesenchymal Transition Rewires the Molecular Path to PI3K-Dependent Proliferation
- (2013) M. B. Salt et al. Cancer Discovery
- EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
- (2012) Ester Sánchez-Tilló et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme
- (2010) Jann N. Sarkaria et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started